Company Profile
Neurogene Stock Price, News & Analysis
- Ticker:
- NGNE
- Exchange:
- NASDAQ
- Sector:
- Biotechnology
- Location:
- Headquartered in the United States and listed on NASDAQ, Neurogene is followed within the biotech universe for its exposure to catalyst-driven execution.
Stock performance
30.86 USD (-4.31%)
Close
Last updated: June 23, 2026 at 00:00
487.65M USD
Market cap
Why the stock is moving
NGNE is trading with a steady catalyst profile while investors wait for the next headline that changes the story.
Company overview
Business overview
Neurogene is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
Geographic Base and Sector Classification
Headquartered in the United States and listed on NASDAQ, Neurogene is followed within the biotech universe for its exposure to catalyst-driven execution.
Business Model Characteristics
Neurogene follows a catalyst-driven model where the market watches how the company turns development work into repeatable value creation.
Position Within the Biotechnology Landscape
Compared with more mature healthcare peers, Neurogene sits closer to the development side of the biotechnology landscape, where timing around data and approvals matters most.
Future catalysts
Recent news
The five most recent feed items are shown below in reverse chronological order.
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of Neurogene (NGNE)?
Neurogene (NGNE) most recently closed at 30.86 USD, a -4.31% move versus the previous session.
What is the market cap of Neurogene (NGNE)?
Neurogene currently has a market capitalization of 487.65M USD on BioPharmSignal.
What does Neurogene do?
Neurogene is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
On which exchange is NGNE stock listed?
Neurogene (NGNE) is associated with NASDAQ, Headquartered in the United States and listed on NASDAQ, Neurogene is followed within the biotech universe for its exposure to catalyst-driven execution., Biotechnology.
What is Neurogene?
Neurogene is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs.
Which conditions is Neurogene targeting with Neurogene?
Neurogene is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
What is Investors?
Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.